JP2025509648A5 - - Google Patents
Info
- Publication number
- JP2025509648A5 JP2025509648A5 JP2024554930A JP2024554930A JP2025509648A5 JP 2025509648 A5 JP2025509648 A5 JP 2025509648A5 JP 2024554930 A JP2024554930 A JP 2024554930A JP 2024554930 A JP2024554930 A JP 2024554930A JP 2025509648 A5 JP2025509648 A5 JP 2025509648A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22162533 | 2022-03-16 | ||
| EP22162533.8 | 2022-03-16 | ||
| EP22204783 | 2022-10-31 | ||
| EP22204783.9 | 2022-10-31 | ||
| PCT/EP2023/056591 WO2023174998A1 (en) | 2022-03-16 | 2023-03-15 | Tumor antigens, compounds comprising the tumor antigens kras, tpx2 or aurka and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025509648A JP2025509648A (ja) | 2025-04-11 |
| JP2025509648A5 true JP2025509648A5 (https=) | 2025-04-18 |
| JPWO2023174998A5 JPWO2023174998A5 (https=) | 2025-04-18 |
Family
ID=85601530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554930A Pending JP2025509648A (ja) | 2022-03-16 | 2023-03-15 | 腫瘍抗原、腫瘍抗原ｋｒａｓ、ｔｐｘ２又はａｕｒｋａを含む化合物及びそれらの使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240033336A1 (https=) |
| EP (1) | EP4493209A1 (https=) |
| JP (1) | JP2025509648A (https=) |
| KR (1) | KR20240161969A (https=) |
| AR (1) | AR128799A1 (https=) |
| AU (1) | AU2023235401A1 (https=) |
| CA (1) | CA3252229A1 (https=) |
| CL (1) | CL2024002708A1 (https=) |
| CO (1) | CO2024012166A2 (https=) |
| CR (1) | CR20240374A (https=) |
| DO (1) | DOP2024000166A (https=) |
| IL (1) | IL315096A (https=) |
| JO (1) | JOP20240203A1 (https=) |
| MX (1) | MX2024011238A (https=) |
| PE (1) | PE20242221A1 (https=) |
| TW (1) | TW202346363A (https=) |
| WO (1) | WO2023174998A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118256561A (zh) * | 2024-03-22 | 2024-06-28 | 徐州医科大学 | 靶向双激酶aurka/cdk7的疫苗在治疗实体瘤中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2291071B1 (es) | 2005-06-13 | 2009-03-16 | Proyecto De Biomedicina Cima, S.L. | Agentes y metodos basados en el uso del dominio eda de la fibronectina. |
| DE102008050860A1 (de) | 2008-10-08 | 2010-04-15 | Dorothee Von Laer | LCMV-GP-VSV-Pseudotypvektoren und tumorinfiltrierende Virenproduzentenzellen zur Therapie von Tumoren |
| US20120237535A1 (en) | 2009-09-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Therapeutic Compositions For The Treatment of HPV-Induced Diseases |
| WO2011101332A1 (en) | 2010-02-16 | 2011-08-25 | Proyecto De Biomedicina Cima, S.L. | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
| US9555074B2 (en) | 2010-10-08 | 2017-01-31 | Regents Of The University Of Minnesota | Annexin II compositions |
| WO2014093602A1 (en) * | 2012-12-14 | 2014-06-19 | Profectus Biosciences, Inc. | Compositions and methods for treating and preventing hepatitis c virus infection |
| US20180133327A1 (en) | 2015-03-16 | 2018-05-17 | Amal Therapeutics Sa | Cell Penetrating Peptides and Complexes Comprising the Same |
| DK3515476T3 (da) * | 2016-09-21 | 2024-09-02 | Amal Therapeutics Sa | Fusion der omfatter et cellepenetrerende peptid, en multiepitop og en trl-peptidagnost til behandlingen af cancer |
| JP2020514321A (ja) * | 2017-02-01 | 2020-05-21 | モデルナティーエックス， インコーポレイテッド | 活性化がん遺伝子変異ペプチドをコードする免疫調節治療ｍＲＮＡ組成物 |
| AU2018247958A1 (en) * | 2017-04-07 | 2019-10-10 | Hookipa Biotech Gmbh | Arenavirus particles to treat solid tumors |
-
2023
- 2023-03-15 TW TW112109579A patent/TW202346363A/zh unknown
- 2023-03-15 IL IL315096A patent/IL315096A/en unknown
- 2023-03-15 PE PE2024001974A patent/PE20242221A1/es unknown
- 2023-03-15 CA CA3252229A patent/CA3252229A1/en active Pending
- 2023-03-15 US US18/184,000 patent/US20240033336A1/en active Pending
- 2023-03-15 JP JP2024554930A patent/JP2025509648A/ja active Pending
- 2023-03-15 AR ARP230100644A patent/AR128799A1/es unknown
- 2023-03-15 WO PCT/EP2023/056591 patent/WO2023174998A1/en not_active Ceased
- 2023-03-15 EP EP23710901.2A patent/EP4493209A1/en active Pending
- 2023-03-15 CR CR20240374A patent/CR20240374A/es unknown
- 2023-03-15 KR KR1020247034368A patent/KR20240161969A/ko active Pending
- 2023-03-15 MX MX2024011238A patent/MX2024011238A/es unknown
- 2023-03-15 AU AU2023235401A patent/AU2023235401A1/en active Pending
-
2024
- 2024-08-23 DO DO2024000166A patent/DOP2024000166A/es unknown
- 2024-09-06 CO CONC2024/0012166A patent/CO2024012166A2/es unknown
- 2024-09-10 CL CL2024002708A patent/CL2024002708A1/es unknown
- 2024-09-15 JO JOJO/P/2024/0203A patent/JOP20240203A1/ar unknown